DELiveri™: A Conjugate Discovery Platform, Empowered by Combinatorial Chemistry & AI, for ex-Hepatic Selective Delivery of Synthetic RNA
Time: 12:00 pm
day: Conference Day One
Details:
• The DELiveri™ platform ushers in a new era of precision in nucleic acid medicine, enabling high-throughput screening (HTS) of cell-specific targeting small molecules
• DELiveri™ uses a proprietary engineered genetic circuit that transforms screened cells into MOLECULAR RADARs
• Once coupled with DNA-encoded libraries (DELs) and AI for analysis, HTS outputs generate quantitative signals unique to cytoplasm-available entities
